ENDONOVO THERAPEUTICS, INC. Stock Issued During Period, Shares, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, issued for services for the quarter ending 2023-09-30 was 29.95M shares.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, issued for services for the quarter ending 2023-06-30 was 1.00M shares.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, issued for services for the quarter ending 2023-03-31 was 12.85M shares.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, issued for services for the quarter ending 2022-09-30 was 0.00 shares.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, issued for services for fiscal 2015 was 6.52M shares.
| Period end | Stock Issued During Period, Shares, Issued for Services 3 month | Stock Issued During Period, Shares, Issued for Services 12 month |
|---|---|---|
| 2023-09-30 | 29.95M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-29 | |
| 2023-06-30 | 1.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | |
| 2023-03-31 | 12.85M shares 10-Q · filed 2023-05-22 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-29 | |
| 2020-09-30 | 360.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | |
| 2018-09-30 | 4.03M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2017-03-31 | 747.34K shares 10-Q · filed 2017-05-12 | |
| 2016-06-30 | 750.00K shares 10-Q · filed 2016-05-27 | |
| 2016-03-31 | 901.50K shares 10-K · filed 2016-05-17 | |
| 2015-12-31 | 1.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | 6.52M shares 10-K · filed 2017-04-17 |
| 2013-06-30 | 4.25M shares 10-Q · filed 2015-08-19 |